Your browser doesn't support javascript.
loading
Progress in the study of antiviral activity of cepharanthine against SARS-CoV-2 / 南方医科大学学报
Article de Zh | WPRIM | ID: wpr-941027
Bibliothèque responsable: WPRO
ABSTRACT
As a member of the dibenzyl isoquinoline alkaloid family, cepharathine is an alkaloid from the traditional Chinese medicine cepharathine, which is mainly used for treatment of leukopenia and other diseases. Recent studies of the inhibitory effect of cepharathine against SARS-CoV-2 have attracted widespread attention and aroused heated discussion. As the original discoverer of the anti-SARS-CoV-2 activity of cepharanthine, here we briefly summarize the discovery of cepharanthine and review important progress in relevant studies concerning the discovery and validation of anti-SARS-CoV-2 activity of cepharathine, its antiviral mechanisms and clinical trials of its applications in COVID-19 therapy.
Sujet(s)
Mots clés
Texte intégral: 1 Base de données: WPRIM Sujet principal: Antiviraux / Benzylisoquinoléines / SARS-CoV-2 / COVID-19 Limites: Humans Langue: Zh Journal: Journal of Southern Medical University Année: 2022 Type de document: Article
Texte intégral: 1 Base de données: WPRIM Sujet principal: Antiviraux / Benzylisoquinoléines / SARS-CoV-2 / COVID-19 Limites: Humans Langue: Zh Journal: Journal of Southern Medical University Année: 2022 Type de document: Article